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Aims of the thesis 
The clinical presentation of psychotic disorders (e.g. on positive, negative symptoms or cognitive 
impairment) is heterogeneous and symptoms differ in origin, structure and in clinical expression. 
Although this notion has been widely acknowledged (Markova and Berrios, 1995), symptom 
differences are still overlooked in clinical practice and proper statistical analysis in research is lacking. 
The heterogeneity of psychotic disorders calls for adequate statistical approaches to clarify the 
underlying structures. Clustering techniques or group-based trajectory techniques have been 
implemented to form meaningful homogeneous symptom subtypes of subjects using longitudinal 
data (Goldstein and Shemansky, 1995; Jablensky, 2006; Joyce and Roiser, 2007; Dawes et al., 2011; 
Quee et al., 2014). The main aim of the thesis is to explore heterogeneity in cognitive functioning and 
in clinical symptoms in schizophrenia patients and their unaffected siblings using both cross-sectional 
and longitudinal data. 
To reach the objective of the thesis, a number of different steps were taken. Firstly, I 
compared the performance of 14 cluster indices to identify the right number of cognitive subtypes. 
For this, I performed simulations of various number of clustering scenarios, based on a real case 
study with cognitive measures (Chapter 2). Secondly, I explored the heterogeneity of clinical 
symptoms and of cognitive functioning in patients with psychosis and their unaffected siblings in a 
longitudinal setting by implementing the group-based trajectory modeling approach (Chapter 3 and 
4). Thirdly, I examined also the unobserved heterogeneity of symptoms by using factors (neuro and 
social cognition) to predict the development of psychotic experiences over time by applying mixture 
of generalized linear mixed effects modeling (Chapter 5). Fourthly, I described the heterogeneity in 
the domain of comorbid diseases among patients with schizophrenia, their unaffected siblings, and 
healthy controls. The effects of gender, age and familial liability on the prevalence of multimorbidity 
were also investigated (Chapter 6). Finally, I studied the risk factors that were associated with the 
duration of untreated psychosis (DUP) in a large sample that represented the treated prevalence of 
non-affective psychotic disorders (Chapter 7). All studies in this thesis were performed within the 
framework of the Genetic Risk and Outcome of Psychosis (GROUP) project, a longitudinal multicenter 
cohort study in the Netherlands and Belgium.  
 
Summary of main findings  
The first major challenge was to correctly identify the number of clusters in a complex heterogeneous 
dataset. Over the last decades, different indices have been developed to quantify the number of 
clusters. In chapter 2, I investigated the most promising indices for detecting the correct number of 
clusters on the basis of hierarchical clustering (with Ward’s agglomerative method) in cross-sectional 
data. The indices were investigated on (i) how well they would discriminate between a single and 
multiple cluster solution and (ii) on how well they can predict the number of clusters in a multi 
cluster solution. I showed that, out of fourteen indices, the Duda and Hart (DH), Hartigan (H), and 
Gap/pc indices were best performing in the simulation study involving eight-dimensional cognitive 
outcome variables taken from a real case study of schizophrenic patients. These indices predicted 
with high probabilities the simulated number of clusters within the range of one cluster difference 




in combination with WGap/pc was capable of answering the question if a multiple cluster solution 
was present or not. 
Next, I derived subtypes of patients with schizophrenia and their unaffected siblings 
longitudinally in terms of cognitive functioning (composite score) and in terms of clinical symptoms. 
For this, in chapter 3, I applied group-based trajectory modeling. Five trajectories of patients were 
found. These trajectories were labeled as ‘normal’ (26.7%) as their z-scores for the composite 
cognitive measures were in the standard normal range; ‘mild alterations’ (30.4%) as their 
performances were 0.5 SD below normal; ‘moderate impairment’ (28.4%) as their z-scores ranged 1 
SD below normal; ‘severe impairment’ (10.7%) as their z-scores were more than 1 SD below normal. 
A small group of patients was labeled ‘high performer’ (3.8%), as they performed better than healthy 
controls. In a similar vein, four trajectories for siblings were identified. They were labeled as ‘normal’ 
(37.6%), ‘mild alterations’ (25.1%), ‘moderate impairment’ (13.0%) and ‘high performer’ (24.2%). 
These distinct trajectories of both patients and siblings turned out to be stable and persistent over 
time. Impaired patients and siblings were from ethnic minorities, younger age, low IQ and exhibited 
poorer premorbid functioning compared to the normal group. Severely impaired patients with 
schizophrenia also had more severe symptomatology, (i.e. poorer performance on PANSS five-factor 
model). Next, I hypothesized that subtype of patient predicted the subtype of sibling within the 
sibling-patient analysis. I considered sibling subtype (multi-category) as dependent and patient 
subtype as independent categorical variables. Given the family structure of the data (as siblings-
patients belong within the same family), clustered multinomial logistic regression analysis was 
conducted taking into account family membership as a random effect. Results showed the familial 
correlation (i.e. the intra-class correlation coefficient between pairs of index patients and their 
unaffected siblings) accounted for 27 percent of total variation. I showed that cognitive subtypes of 
patients significantly predicted the cognitive subtypes of siblings. The poorer the cognitive profile of a 
patient, the better it predicted (OR 10.07, 95% CI 4.15-24.44) that of a more cognitively impaired 
sibling. Similarly, patients with moderately impaired cognition predicted his/her unaffected siblings 
to be moderately cognitive impaired (OR 5.7, 95% CI 2.77-11.70). Another finding was that severely 
impaired patients predicted much less (OR 0.24, 95% CI 0.09-0.63) the sibling to be a higher 
performer. The relative risks of mild alterations and moderate impaired group of patients also 
offered less predictive value to the high performance profiles of siblings. It is conceivable that the 
high performance of unaffected siblings is unlikely to be predicted given the status of their paired 
probands.  
Besides investigating the cognitive heterogeneity, I also further explored the heterogeneity in 
negative symptoms. Recent literature has revealed that in fact there are two subdomains of negative 
symptoms, typically known as social amotivation (SA) and expressive deficits (ED) (Messinger et al., 
2011; Foussias et al., 2014; Liemburg et al., 2013). To date, there are few studies describing the 
longitudinal course of SA and ED, and conclusions are mixed (Ergul and UCok, 2015; Norman et al., 
2015; Galderisi et al., 2013). In chapter 4, I investigated i) whether the course of SA and ED changed 
during the course of six years. Using linear mixed models, I found that both SA and ED displayed a 
small but significant decrease in severity over time. Next, I examined ii) whether baseline levels of SA 
and ED could predict functioning and quality of life six years later. Multiple linear regression analysis 




was conducted and the results indicated that lower baseline levels of SA symptoms predicted higher 
levels of global functioning, of social functioning, better quality of life and more engagement in work 
or study activity six years later. In the same line, lower baseline levels of ED symptoms predicted 
higher levels of global and social functioning six years later.  
I then aimed iii) to identify subgroups based on the course of SA and ED over a period of six 
years. Here, I again applied group-based trajectory modeling in order to identify the correct number 
of subgroups. Each of the two subdomains yielded four subgroups with differing courses of negative 
symptom levels. Within both subdomains, a large group of patients (±60%) with steady low levels of 
symptoms and two subgroups (both ±15%) with either symptom-level increase or symptom-level 
decrease were found. Furthermore, within SA, a small subgroup (±6%) showed decreasing symptom 
levels over time after having started at a higher symptom levels, whereas within the ED subdomains, 
another small group (±6%) was continuously experiencing high symptom levels.  
I further investigated iv) the relationship between subgroups within SA and ED and 
functioning and quality of life over the course of six years. Linear and generalized linear mixed effects 
modeling were conducted to unravel the relationships. The stable-low SA group had better functional 
outcome as measured by the Global Assessment of Functioning (GAF), Social Functioning Scale (SFS) 
and World Health Organization Quality of Life (WHO-QOL) at all time points. The stable-low ED 
patient-group also performed way better on the GAF and SFS, at baseline and after three years of 
follow up, but not six-years after baseline. People with decreased-to-low SA-symptoms had a 
significantly lower chance of living independently after three years of follow up and reported higher 
levels of both, global functioning and quality of life after six years compared to low SA symptoms. 
People with an increased SA had lower chance to have a regular work activity and reported lower 
functioning and lower quality of life over the course of six years. In a similar way, patients with 
increased ED showed significantly lower chance of work activity and lower levels of functioning than 
low ED over time. In addition, decreased ED was associated with better global functioning over the 
course of six years. 
In summary, results show that there is considerable heterogeneity in the course of 
subdomains over time and suggest that negative symptoms are less stable than was previously 
assumed. Subgroups were identified within SA and ED, showing a different course of symptoms over 
time. Moreover, the two domains are clinically relevant as they differentially relate to the level and 
course of outcomes.  
Besides cognitive and symptoms heterogeneity, I also studied psychotic experiences in 
relatives of individuals with psychotic disorders. Psychotic experiences are heterogeneous over time 
and this heterogeneity may be explained by different factors (e.g. neuro- and social cognition). To 
learn more about the development of psychotic experiences over three years, I investigated factors 
that were known to predict psychosis. To this end, in chapter 5, I applied mixture of generalized 
linear mixed effects models to examine the reported development of psychotic experiences in 
siblings of people with psychosis and its relationships to neuro- and social cognition. Poorer verbal 
learning performance (operationalized as the score on immediate recall) predicted the occurrence of 
PE after three years and also the distress associated with these psychotic experiences. Moreover, 




with a decrease in psychotic experiences three years later. Baseline distress was associated with 
poorer recognition of angry and neutral faces and strikingly, with better performance on the Benton 
facial recognition test at baseline. In conclusion, verbal learning and ToM were found to be predictive 
of frequency and course of psychotic experiences over three years respectively. In addition, verbal 
learning and ToM were also predictive of the distress that psychotic symptoms were causing. 
In chapter 6, the heterogeneity in the domain of somatic diseases and complaints among 
patients with schizophrenia, their unaffected siblings and subjects from the healthy population is 
described. I investigated the effect of familial liability to psychosis along with gender and age on the 
prevalence of multimorbidity of diseases and complaints. In summary, familial liability had a 
significant effect on multimorbidity of complaints and lifetime diseases (with/without psychiatric 
comorbidity) respectively. Moreover, multimorbidity was strongly associated with female gender 
overall. In people with psychosis, multimorbidity was not limited to the elderly but also affected 
young individuals. The risk of multimorbidity caused by familial liability for psychosis was consistent 
across gender and age group, meaning that familial liability for psychosis is in itself a strong 
independent determinant of multimorbidity. 
Finally, in chapter 7, I identified risk factors that were significantly associated with the 
duration of untreated psychosis (DUP). DUP is defined as the time from the emergence of the first 
psychotic episode to the initiation of adequate treatment. Migration status, age at onset of psychotic 
disorder and gender were significantly associated with DUP. In conclusion, first generation immigrant 
patients, individuals with an early onset of their psychotic disorder and male patients were at risk of a 
longer DUP. Our findings were in line with the results of a number of smaller studies (Sterk et al., 
2010; Boonstra et al., 2012; Nerhus et al., 2015; Schimmelmann et al., 2008; Cotton et al., 2006). First 
generation immigrants seem to be less familiar with the concept of mental illness and also with 
mental health services (Wolff et al., 1996). They may be less likely to perceive themselves as having a 
psychiatric problem or to be in need for treatment (Commander et al., 1999).  
 
From heterogeneity to endophenotype 
Cognitive impairment and negative symptoms are core features of the presence and severity of 
psychosis (American Psychiatric Association, 2013). There is ample evidence for significant cognitive 
heterogeneity in schizophrenia. This heterogeneity is explained by a general loss of function, varying 
from patient to patient, or by impairment over the various cognitive abilities (e.g. executive function 
and working memory) (Joyce et al., 2005; Joyce and Roiser, 2007). Previous literature reported that 
the cognitive test performance of patients with schizophrenia was extremely heterogeneous 
(Goldstein, 1990; Joyce et al., 2005; Joyce and Roiser, 2007). So far, only two studies demonstrated 
cognitive heterogeneity in the relatives of patients with schizophrenia (Quee et al., 2014; Sautter et 
al., 1995). I extended the findings of Quee et al. (2014) by showing that cognitive heterogeneity in 
people with schizophrenia and in their unaffected siblings was stable for the long-term course.  
Another type of heterogeneity (i.e. negative symptom heterogeneity) has also been observed 
in psychosis (Seaton et al., 1999; Seaton et al., 2001; Liemburg et al., 2013; Stiekema et al., 2016). In 
both cases, I confirmed the stable groupings of patients. The heterogeneity was confirmed by 
examining the relationships with course of illness, clinical, and functional outcomes. Therefore, these 
groupings may be considered as candidate subtypes.  




Furthermore, I underpinned the arguments for cognitive subtypes to be considered good 
“endophenotypes” by fulfilling the following criteria (Miller and Rockstroh, 2013; Ritsner and 
Gottesman, 2011; Hasler et al., 2006): 
i) stable trait: cognition as well as cognitive subtypes were shown to be highly stable over 
time and associated with illness of schizophrenia, ii) familial liability: the cognitive performance of 
family members of patients with schizophrenia is located in between cognitive performances of 
patients and healthy population (i.e. familial correlation), iii) cognitive subtypes were correlated with 
other clinical and socio-demographic parameters, and iv) cognitive functioning cannot be seen by the 
“naked eye”. Thus, unraveling the heterogeneity of cognition yielded meaningful cognitive subtypes 
for both patients and their unaffected siblings, so called endophenotypes, being located somewhere 
between the genotype (DNA) and the phenotype (clinical symptoms). 
Regarding negative symptoms as well as symptom subtypes: they are less stable but still 
persistent over time. Their significant relationships with other external parameters define them as 
subtype. However, they cannot be considered as endophenotype of schizophrenia, as they are part 
of the phenotype. 
 
Not one but many forms of schizophrenias 
A number of analytical techniques have been used to address the issue of cognitive heterogeneity. 
One option is to categorize cognitive functioning into neuro-psychologically normal and impaired 
subgroups based on standard cut-off scores for cognitive batteries or expert’s judgment of cognitive 
profile (Seaton et al., 2001). However, categorizing patients into normal or impaired groups 
supposedly underestimates the actual heterogeneity in schizophrenia based on expert’s cut-off 
scores. This limitation is addressed adequately using exploratory or model-based statistical 
techniques. Therefore, an alternative and more objective option is the application of clustering, like 
the model-based trajectory techniques to classify homogeneous cognitive subtypes to identify 
disease severity (Goldstein and Shemansky, 1995; Seaton et al., 1999; Seaton et al., 2001; Jablensky, 
2006; Joyce and Roiser, 2007; Dawes et al., 2011; Quee et al., 2014). A number of studies in literature 
used cluster analysis (e.g. hierarchical or K-means) while other used latent profile analysis and 
reported four or five-cluster subtypes of patients with schizophrenia. These findings were stable and 
consistent although different studies used different test batteries (Goldstein, 1990; Heinrichs and 
Awad, 1993; Heinrichs et al., 1997; Goldstein et al., 1998; Seaton et al., 2001; Joyce et al., 2005; Joyce 
and Roiser, 2007; Bora et al., 2016). Likewise, several researchers investigated at least four potential 
subtypes of clinical symptoms (e.g. on the PANSS) of schizophrenia such as positive, negative, mixed 
and disorganized symptoms (Dollfus et al., 1996; Lykouras et al., 2001; Seaton et al., 2001). 
Moreover, there is also evidence that the negative symptoms are heterogeneous, yielding two 
subdomains i.e. social amotivation (SA) and expressive deficit (ED) (Liemburg et al., 2013; Stiekema et 
al., 2016). By group-based trajectory modeling, I confirmed that indeed patients are heterogeneous 
in both subdomains supporting the two dimensional approach of Liemburg et al. However, the DSM-
V (American Psychiatric Association, 2013) favours one dimension. 
Together with neurocognition and clinical symptoms, psychotic experiences of siblings of 
patients with schizophrenia are heterogeneous and are explained by neuro- and social-cognition 




line with the findings of our study (chapter 5), one study found that poorer theory of mind predicted 
the experience of delusions in children with auditory hallucinations after three years (Bartels-Velthuis 
et al., 2011). Fragmenting frequency of psychotic experiences and distress according to their true 
distributions and their associations with neuro-and social cognition, I conclude that psychotic 
experiences are heterogeneous over time. Apart from heterogeneity of clinical symptoms, I conclude 
that domains of somatic diseases and complaints are heterogeneous according to familial liability 
group as the prevalence of multimorbidity of complaints and lifetime diseases in siblings fall in 
between the prevalences of patients with schizophrenia and member of healthy population. One 
study showed the familial liability (controls<siblings<patients) as a risk factor for cognitive functioning 
(Krabbendam et al., 2001), although this is not the same as my conclusions on multimorbidity. 
Based on findings from chapter 2 to 5, I conclude in line with Bleuler’s hypothesis (1950) that 
there are many “schizophrenias” rather than a single form of schizophrenia (Bleuler, 1950). There are 
several considerations that would favor the cognition or symptom subtypes in schizophrenia rather 
than a continuum form of schizophrenia. First of all, the cluster analysis and trajectory modeling 
showed both level and pattern differences on external variables such as age, education, IQ, age of 
onset and premorbid functioning. Secondly, although there are clear differences in level of 
performances, the differences in average standardized cognition scores between patients and 
siblings are often dramatic, making it hard to imagine that there would be one underlying continuum 




The strengths and limitations of the studies in this thesis have been addressed chapter-wise. Overall, 
the clustering techniques are appropriate to identify subtypes. The methodological strength in 
chapter 2 is that of applying extensive simulation studies that were based on a case study of eight 
dimensional measures to determine the number of clusters, making this a “real world” exercise. So 
far, performances of indices were studied mainly with artificial low dimensional simulated data 
(Milligan and Cooper, 1985; Tibshirani et al., 2001). In general, I studied only the indices which would 
fit best with the relative simple but frequently used methods of clustering. Thus, the study 
investigated the proposed indices using a sequential stopping criterion for hierarchical clustering. 
This means cutting the branches in the dendrogram horizontally. However, cutting branches can also 
be performed more dynamically making cuts higher and lower in the tree and not at the same height 
for the whole tree. It would be challenging and highly interesting to find out whether dynamic cutting 
would improve the performance of certain indices. Moreover, I focused only on Euclidean distance 
measure and Ward’s agglomerative technique for identifying the number of clusters. It may be 
possible that some of the indices will provide different results when other distances or dissimilarity 
measures are used to merge subgroups within hierarchical clustering.  
 The strength of group-based trajectory modeling (GBTM) (Nagin, 2014) for analyzing 
developmental cognitive trajectories over time is that it is easily understood graphically and it 
provides simple and straightforward tabular data summaries. This method does take into account the 
missing outcome, covariates and patterns within the same model (Haviland et al., 2011) whilst other 
techniques such as growth-curve modeling or latent profile analysis do not.  




Some limitations should also be mentioned in this regard. Sometimes GBTM provides a very 
small group of individuals which will not be representative for further analysis. For example, I found 
five meaningful subtypes in patients according to logged Bayes factor, but a small group of patients 
(3.8%) with high cognitive performance did not predict moderate impairment of siblings using sib-
pair analysis. This may imply that the high performers in patients are a cluster artifact, but this is 
difficult to establish in unsupervised clustering.  
Composite scores were computed using mean z-scores for all eight cognitive measures that 
were age and gender specific. We did not adjust for education as we believe that years of education 
is a measure, albeit rough, of “prodromal” cognitive functioning in schizophrenia. For that reason, it 
would not make sense to artificially control for years of education (Seaton et al., 2001).  
Generating composite cognition scores might have an impact on finding meaningful 
trajectories instead of using multivariate cognitive tests. This is one of the limitations of trajectory 
modeling (Jones et al., 2001) which may deal with only one variable at a time measured over at least 
three assessments. Thus, here information may have been lost by using a composite score.  
There may have been some selection bias in data collection with respect to patients or 
siblings compared to controls, as most of the controls were selected by random mailing.  
Several additional limitations should also be mentioned on the subtypes for negative 
symptoms that were presented in chapter 4. We do not know whether changes in negative 
symptoms are due to relief of secondary negative symptoms, for example by reduced positive 
symptoms, depressive symptoms or antipsychotic medication (Carpenter and Kirkpatrick, 2015). 
Further, the duration between assessments is three years, which is large. Short interval may provide 
a clearer picture of negative symptoms persistency instead of observing at three years interval.  
More importantly, there is a distinction between clusters and subtypes. If one conducts 
cluster or trajectory analysis and clusters/trajectories are determined, it does not mean that they 
reflect actual subtypes because cluster membership may be determined largely by level of 
performance. An extensive external validity must be established when cluster/trajectory becomes a 
subtype. For example, in schizophrenia, we usually want to see clinical, cognitive, neurobiological, 
and genetic evidence of the stability of the cluster/trajectory under study.  
The assessment of psychotic experience at three-year follow-up might have been biased, 
resulting in observed decreases in frequency and distress of psychotic experiences. There may also be 
reporting bias since psychotic experiences are very personal experiences and thoughts which were 
assessed with a self-reported questionnaire.  
The overall strength of the study is the use of a broad range of neurocognitive variables 
together with social cognition of healthy siblings of patients with schizophrenia, providing a 
comprehensive picture of the possible factors related to psychotic experiences. The methodology of 
using a mixture of generalized linear mixed effects models is unique for the predictive values of 
neuro- and social cognitive parameters on psychotic experiences. Measuring psychotic experiences in 
siblings yielded lot of zeros (i.e. no experiences) together with psychotic experiences ranging from 
‘sometimes’ to ’nearly always’. In this situation, the weighted scores of psychotic experiences 




mixture of generalized linear mixed effects models (Tooze et al., 2002) would provide unbiased 
results.  
The multimorbidity study was mainly based on self-reported diseases, clinical complaints and 
medication history. There might be a reporting bias regarding the diagnosis of the disease. The 
operational definition of multimorbidity is another concern. The majority of studies have defined 
multimorbidity as two or more, whereas others counted three or more concurrent diseases (Fortin et 
al., 2005; Jacobi et al., 2004; Fuchs et al., 2012; Willadsen et al., 2016). In this thesis, multimorbidity is 
defined as two or more diseases or complaints. Another concern is that I considered only gender, age 
and familial liability, leaving out other reported multiple risk factors (Agborsangaya et al., 2012; De 
Hert et al., 2011) for multimorbidity.  
One of the strengths of this study was statistical methodological point of view. I applied 
generalized linear mixed effects models taking into account family structure as random effect to 
identify the risk factors for multimorbidity in psychosis. Additionally, this is the first study which has 
dealt with a comprehensive list of diseases, either somatic or psychiatric, in schizophrenia patients 
while counting multimorbidity in a cumulative way rather than focusing only on pairwise 
comorbidities (Nuyen et al., 2006; Oreski et al., 2012). The most informative feature of this study was 
the sibling model; whereas most studies emphasized multimorbidity either in healthy subjects or the 
disease population.  
A major strength of duration of untreated psychosis (DUP) is the use of a statistical model 
that takes into account the effect of other candidate factors. I applied ordinal logistic regression for 
categorical DUP and a sensitivity analysis using Cox-proportional hazards model for time-to-event 
DUP. Modeling the data with equally valuable tools and then showing consistent results, makes the 
conclusion on the significant association of first generation migration status and age at onset of the 
psychotic disorder with DUP stronger than just using one analysis technique. One of the concerns is 
that categorization of DUP; there are no agreed-on cutoff points (Marshall et al., 2005). Other 
concerns of the results are that DUP was defined retrospectively and that data collection relied on 
self-reports. 
There is a potential loss of statistical power and efficiency when missing data are present. 
This may lead to biases and incorrect statistical inferences. In chapter 4 and chapter 5, there were 
missing data both on outcomes and independent variables. Both chapters are assumed that the 
missingness is conditional on the observed data but independent of the unobserved values, which is 
called missing at random (MAR) (Allison, 2002). Maximum likelihood (ML) and multiple imputation 
(MI) (Rubin, 1987) methods usually handle the missingness under MAR. I employed a fully conditional 
specification (FCS) predicted mean matching (PMM) multiple imputation (MI) method to impute 
missing values for both continuous and categorical variables (van Buuren, 2007) and analyzed the 
data with appropriate statistical models. Apart from PMM, Bayesian MI method is another good 
approach to handle missingness under MAR assumptions. It uses an iterative algorithm to impute 
data and it splits the multivariate missing problem into a series of univariate problems based on the 
assumed distribution of the multivariate missing variables (e.g. multivariate normal for continuous 
variables, multinomial loglinear for categorical variables) (Schafer, 1997). However, if the missingness 
is Missing Not At Random (MNAR), i.e. missingness depends on the unobserved data and missingness 




is no longer ignorable, a model for the probability of missing data needs to be specified. This 
probability model is then combined with a linear mixed model for the measurement process. 
Selection and pattern mixture models are two alternative and important approaches for dealing with 
MNAR. A selection model is the joint distribution of the measurement and the missing mechanisms 
into the marginal measurement distribution and the dropout distribution conditional on the 
measurements (Thijs et al., 2002; Verbeke and Molenberghs, 2000). A pattern-mixture model is the 
joint distribution of the measurement and response mechanisms into a different measurement 
model for all response patterns, and the marginal response distribution (Thijs et al., 2002; Michiels et 
al., 2002; Verbeke and Molenberghs, 2000). Pattern mixture model is a sensitivity analysis within a 
fully Bayesian modeling framework that could be used to handle the missingness under MAR (Little, 
1995; Little, 1993; Michiels et al., 2002; Thijs et al., 2002). 
 
Which clustering technique to use? 
There are several clustering algorithms and each of them uses different induction principles. 
Literatures suggest that clustering methods are categorized into hierarchical, partitioning methods, 
model-based and grid-based methods (Fraley and Raftery, 1998; Han and Kamber, 2001; Fraley and 
Raftery, 2002; Estivill-Castro and Yang, 2000; Rokach and Oded, 2005).  
A strength of hierarchical cluster analysis is that it always confirms that the most similar 
observations are in the same clusters. However, this is also its major weakness. Once a cluster is 
made, the observations within this cluster will never be relocated to other clusters. This problem 
does not occur with partitioning methods e.g. K-means or K-medoids. Additionally, partitioning 
methods are easy to interpret, simply to implement and faster to compute with large datasets. 
However, this method is sensitive to noisy data and outliers. Model-based or density-based methods, 
e.g. latent class/profile analysis, trajectory and growth-curve modeling, assume that observations 
would come from a mixture of distributions (Muthen and Shedden, 1999; Muthen and Muthen, 
2000; Rokach and Oded, 2005). Latent class/profile analysis, trajectory or growth-curve modeling are 
subject-specific finite mixture modeling approaches, meaning that the focus is on the subject’s 
unique pattern of characteristics and therefore focuses largely on identifying subtypes of individuals 
with similar patterns (Muthen and Muthen, 2000; Rokach and Oded, 2005; Jung and Wickrama, 
2008). The model-based approaches assume a certain type of mixtures of distributions, while 
partitioning methods do not make any assumption on the distribution. Thus, the model-based 
approaches are theoretically superior to any other approaches when the distributional assumption is 
known. The algorithm takes into account the uncertainty when allocating observations to clusters. 
These approaches use to estimate the posterior probabilities that an individual will be categorized 
into a particular group of risk patterns (Shah et al., 2014). However, all approaches need a pre-
defined number of clusters. Hierarchical clustering can be considered a prior analysis of K-means or 
latent profile analysis in cross-sectional studies and this thesis showed that it may be suitable to 
detect the number of clusters. Other clustering approaches e.g. decision trees, neural networks and 








Cognitive functioning is moderately to severely impaired in patients with schizophrenia and their 
unaffected siblings and more than 80% of patients show significant impairment (Keefe and Fenton, 
2007; Keefe and Harvey, 2012; Quee et al., 2014). This impairment group has an impact on outcomes 
such as occupational, social, clinical and economic functioning and emergent for treatment target. 
Research for pharmacological treatment is ongoing for improving cognitive function in schizophrenia 
but the results are not very convincing so far (Keefe and Harvey, 2012; Marder, 2006). The psycho-
social intervention programs e.g. Cognitive Remediation (CR) is likely to be a safer way to improve 
cognitive functioning than pharmacologic treatment. The CR program produces modest 
improvements for patients with schizophrenia (Bora et al., 2009; Keefe and Harvey, 2012). Subtyping 
patients, especially severe cognitive impaired and severe symptom group, may be eligible for 
psychosocial interventions. A promising approach is cognitive adaption treatment (CAT), a method 
that takes into account the persistency of the cognitive impairments, while providing practical means 
to overcome these handicaps in real life situations (Quee et al., 2014).  
Attention should be taken on subdomains of negative symptoms, especially when patients 
are severely ill. Evidence suggests there are deficits in anticipatory pleasure and defeatists beliefs 
from SA (Messinger et al., 2011; Foussias and Remington, 2008). Cognitive Behavioral Therapy (CBT) 
may be a suitable intervention for changing these beliefs. In addition, learning to anticipate on the 
experience of pleasurable events could possibly reduce SA. In this thesis, a significant association of 
ED with functioning was found after controlling for neuro-cognition. Therefore in chapter 4, we 
suggested that interventions targeting expressive skills such as Social Skills Training (Shean, 2009), 
could possibly improve ED. Though there is debate on the effectiveness of Social Skills Training, it has 
shown to be more effective in reducing negative symptoms than other psychosocial interventions 
(Turner et al., 2014).   
Additionally, chapter 7 demonstrated that DUP was longer for patients being younger at 
onset of the psychotic disorder, for first generation immigrant patients and for male patients. 
Literature showed that longer DUP predicts worse symptoms at admission (Drake et al., 2000). Early 
implementation of intensive psychosocial intervention services may be necessary to shorten DUP, 
since the effect of DUP on recovery is greatest in the early stages of illness.  
 
Future directions  
Directions for statistical development 
I elaborated the methodological aspects of several indices of hierarchical clustering technique using 
simulation studies in chapter 2. Overcoming some limitations of hierarchical and partitioning 
clustering, it would be of interest to use a multivariate finite mixture model, which classifies 
observations on the basis of probability estimated from Gaussian mixture modeling in cross-sectional 
studies. This method produces posterior distributions of all cluster parameters, proportions and 
cluster membership probabilities for all subjects (Kass and Raftery, 1995; Raftery and Dean, 2006). It 
would also be of interest to use clustering approach on multivariate non-normally distributed data 
(e.g. mixtures of other distributions).  




Another focus would be extending clustering indices and apply those indices to trajectory 
modeling framework to confirm the number of subtypes (chapter 3 and 4). The performance of 
group-based trajectory analysis over growth-curve modeling and linear mixed effects modeling is less 
well known. Therefore, future studies may investigate the performance of group-based trajectory 
modeling on the selection of clusters using extensive simulations. So far, no one has investigated how 
well GBTM would detect the number of clusters and the trajectories in finite studies.  
In longitudinal data, most methods deal with just one outcome variable over time to 
determine the number of clusters. It might be of a great interest to develop multivariate longitudinal 
clustering techniques, i.e. extending the group-based trajectory modeling to multivariate outcomes 
over time. For example, in this thesis, eight cognitive tests are formed into one composite measure 
to be able to identify the number of clusters and its trajectories. I would expect more subtle 
trajectories and different clusters if eight cognitive tests could be jointly incorporated into the 
trajectory modeling over time. 
Another improvement area would be the integration of models for missingness with 
clustering or trajectory modeling. Throughout the thesis, I assumed the missing mechanisms to be 
MAR. It is not examined whether the missing mechanism is MAR or not, since it is impossible to verify 
if it would be MNAR. However, it would be highly interesting to model clustering technique in 
combination with MNAR models, but this requires more research on realistic missingness models in 
schizophrenia research.    
 
Directions for clinical research 
There is still abundant room for improving clinical research. Clustering cognitive functioning and 
symptoms longitudinally in such a way that all observations would be clustered at all time points 
separately, and transition between time points would be modeled by Markov transition matrices. 
This indicates that clustering of one time point will be affected by what chances at the adjacent time 
points (Franzen, 2008).  
Phenotypically patients with schizophrenia and their unaffected siblings are cognitively 
heterogeneous. It may be beneficial to investigate the genetic effect on subtypes to confirm the true 
cognitive subtypes. This is an exciting, new chapter in research, now that polygenic risk scores have 
become available also for schizophrenia (Schizophrenia Working Group of the Psychiatric, Genomics 
Consortium, 2014). It would also be interesting to study whether the cognitive profiling approach is 
predicting functional and clinical outcomes over time.   
It would be informative to use shorter follow-up times to study the effect of SA and ED on 
functioning, clinical outcomes and quality of life. In chapter 4, I demonstrated the effect of individual 
subtypes of SA and ED on outcomes over time. But symptoms of SA and ED tend to co-occur 
(Hartmann-Riemer et al., 2015) and may reinforce each other (Goekoop and Goekoop, 2014). Future 
studies should investigate in such interaction between subtypes of SA and ED, which may provide 
insight in the relationship with outcomes. 
For future research it might be interesting to monitor psychotic symptoms of genetic high risk 
group more frequently (e.g. half-yearly) over time and study associations with neuro- and social 




Netherlands (see www.rgoc.nl/ontheroad). Additionally, one could study the discrete level of 
frequency and distress of psychotic experiences to observe the association with neuro- and social 
cognition instead of using continuum score of frequency and distress of psychotic experiences using 
generalized linear mixed effects modeling.  
In chapter 6, I demonstrated that familial liability is one of the main determinants of 
multimorbidity which acts independently of the other major risk factors of age and gender. It was 
reported that the familial correlation between siblings and index patients were 11 to 16%. It should 
be essential to perform additional genetic analysis to distinguish between the effects of genetic 
liability and intra-familial environmental susceptibility on multimorbidity, applying polygenic risk 
scores for schizophrenia and other complex disorders in the same population. 
Finally, it would be of interest to explore whether ethnicity plays part in the association 
between DUP and migration status. In addition, compelling literature indicates that there is an 
association between a shorter DUP and positive and negative symptoms, functional outcome and 
quality of life (Perkins et al., 2005; Boonstra et al., 2012). Therefore, a longitudinal study should be 




The current thesis describes a number of new findings on the heterogeneity in cognitive functioning 
and clinical symptoms in schizophrenia patients and their unaffected siblings- with a special emphasis 
on the statistical approaches that were applied. In cross-sectional study-designs, hierarchical 
clustering with Duda and Hart (DH) index is the best approach to determine the number of clusters; 
however, model-based clustering approach would be preferable to confirm these clusters. In 
longitudinal studies, group-based trajectory modeling under finite mixture modeling is the best 
approach for summarizing and graphical representing of distinct trajectories.  
Using these approaches, this thesis clearly underlined the validity of cognitive subtypes of 
patients and four subtypes of siblings, being stable and persistent over time and putting forward new 
clinical insights. Similarly, this thesis extent our knowledge on negative symptoms subtypes of SA and 
ED respectively, by demonstrating the performances of these subtypes being persistent on clinical 
and functional outcomes over time.  
Another application of mixture of generalized linear mixed effects modeling on zero-inflated 
continuous outcome of psychotic experiences of siblings helped us to explain this outcome by the 
neuro-and social cognitive functioning, while at same time this yielded valuable insight in the clinical 
development of psychotic symptoms over a three-year time.  
Psychotic experiences and symptoms may be on a continuum, reaching from the general 
non-ill population all the way to the schizophrenia spectrum disorders. Findings in patients and their 
non-affected siblings however confirm that for both cognition and negative symptoms heterogeneity 
exists and meaningful subtypes can be identified. These subtypes may provide new avenues to better 
understanding and more effectively treating people with psychotic disorders.   
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